NCT01494532 - A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease | Biotech Hunter

Enrollment

352

Participants

Timeline

Start Date

April 2, 2012

Primary Completion Date

November 18, 2014

Study Completion Date

November 18, 2014

Conditions

Parkinson Disease

Interventions

DRUG

ropinirole/L-dopa

Ropinirole as adjunctive therapy with L-dopa

DRUG

placebo/L-dopa

Placebo as adjunctive therapy with L-dopa

Trial Locations (52)

1209

GSK Investigational Site, Caba

1650

GSK Investigational Site, San Martín

1841

GSK Investigational Site, Dubnica nad Váhom

10138

GSK Investigational Site, Tallinn

10617

GSK Investigational Site, Tallinn

11375

GSK Investigational Site, Forest Hills

23249

GSK Investigational Site, Richmond

33486

GSK Investigational Site, Boca Raton

33612

GSK Investigational Site, Tampa

91105

GSK Investigational Site, Pasadena

91355

GSK Investigational Site, Reseda

91702

GSK Investigational Site, Trnava

92708

GSK Investigational Site, Fountain Valley

93003

GSK Investigational Site, Ventura

150030

GSK Investigational Site, Yaroslavl

194044

GSK Investigational Site, Saint Petersburg

214019

GSK Investigational Site, Smolensk

305007

GSK Investigational Site, Kursk

371718

GSK Investigational Site, Daejeon

410012

GSK Investigational Site, Saratov

420012

GSK Investigational Site, Kazan'

450000

GSK Investigational Site, Ufa

454136

GSK Investigational Site, Chelyabinsk

463712

GSK Investigational Site, Sungnam

614990

GSK Investigational Site, Perm

620102

GSK Investigational Site, Yekaterinburg

630091

GSK Investigational Site, Novosibirsk

644033

GSK Investigational Site, Omsk

660022

GSK Investigational Site, Krasnoyarsk

2570017

GSK Investigational Site, Viña del Mar

5090145

GSK Investigational Site, Valdivia

7500551

GSK Investigational Site, Santiago

7500710

GSK Investigational Site, Santiago

8260094

GSK Investigational Site, Santiago

01104

GSK Investigational Site, Springfield

C1200AAT

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

C1419AHN

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

C1192AAW

GSK Investigational Site, Ciudad Autónoma de Buenos Aires

B1602DBG

GSK Investigational Site, Buenos Aires

C1133AAW

GSK Investigational Site, Buenos Aires

C1426AHA

GSK Investigational Site, Buenos Aires

974 04

GSK Investigational Site, Banská Bystrica

813 69

GSK Investigational Site, Bratislava

826 06

GSK Investigational Site, Bratislava

831 03

GSK Investigational Site, Bratislava

833 05

GSK Investigational Site, Bratislava

431-070

GSK Investigational Site, Anyang-si

602-715

GSK Investigational Site, Busan

463-707

GSK Investigational Site, Seongnam-si Gyeonggi-do

130-702

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

152-703

GSK Investigational Site, Seoul